The gene testing company can now tell US customers who use its home DNA kit whether they have a genetic risk for any of 10 diseases and conditions.
Gene testing company 23andMe can now tell customers whether they have a genetic risk for any of 10 diseases, including Parkinson’s disease, celiac disease and late-onset Alzheimer’s disease.
The US Food and Drug Administration said on Thursday that 23andMe could market its genetic health risk tests for several diseases and conditions, making it the first home DNA test authorized by the regulator.
This is a big win for 23andMe, which stopped giving health analysis information to US customers in 2013 after being reprimanded by the FDA.
